GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.4000
+0.0206 (5.43%)
At close: Nov 26, 2025, 4:00 PM EST
0.3998
-0.0002 (-0.05%)
After-hours: Nov 26, 2025, 7:45 PM EST
GeoVax Labs Revenue
GeoVax Labs had revenue of $3.35M in the twelve months ending September 30, 2025, up 8.52% year-over-year. In the year 2024, GeoVax Labs had annual revenue of $3.95M.
Revenue (ttm)
$3.35M
Revenue Growth
+8.52%
P/S Ratio
1.85
Revenue / Employee
$197,268
Employees
17
Market Cap
11.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.95M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 81.53K | -303.98K | -78.85% |
| Dec 31, 2021 | 385.50K | -1.44M | -78.86% |
| Dec 31, 2020 | 1.82M | 647.76K | 55.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GOVX News
- 13 days ago - GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - GeoVax Labs Revenue Doubles in Q2 - The Motley Fool
- 4 months ago - GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 months ago - GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 1 year ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 1 year ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha